14.08.2015 • NewsDede WillamsBASFcapacity expansion

BASF’s Starts First China Coatings Resins Plant

BASF has inaugurated its first world-scale production facility for coatings resins in China. The new plant is part of the German group’s approach to stay close to customers worldwide.

Albert Heuser, president Functions Asia Pacific, president and chairman Greater China at BASF, said that as part of the group’s Asia Pacific strategy, “we aim to produce locally 75% of what we sell in Asia Pacific.”

Markus Kamieth, President of BASF Coatings, said the plant is “a vital addition to our global manufacturing network of high quality coatings. It demonstrates our strong commitment to supporting the automotive industry’s long-term growth in Asia Pacific.”

“Together with the automotive coatings plant opened last year, the new coatings unit provides the capacity we need to support its customers’ growth and success”, added Peter Fischer, senior vice president, Coatings Solutions Asia Pacific.

Strategically located next to the new automotive coatings plant within the Shanghai Chemical Industry Park (SCIP), the new resin facility is fully integrated to create more synergies and high production efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.